Biohaven
BHVN
225 hedge funds and large institutions have $2.88B invested in Biohaven in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 101 increasing their positions, 49 reducing their positions, and 56 closing their positions.
145% more call options, than puts
Call options by funds: $23.2M | Put options by funds: $9.47M
106% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 49
2.56% more ownership
Funds ownership: 91.16% → 93.73% (+2.6%)
7% less funds holding
Funds holding: 243 → 225 (-18)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
29% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 56
29% less capital invested
Capital invested by funds: $4.07B → $2.88B (-$1.19B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$57.3M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$47.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.1M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$35.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$30M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$80.8M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$67.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$26.8M |
| 5 |
Jennison Associates
New York
|
-$14.5M |
BHVN Hedge Fund Activity: Q2 2024 in Review
225 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q2 2024, worth a combined $2.88B — down 29% from $4.07B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of BHVN and 40 opened new positions — a net loss of 16 holders — while 49 trimmed existing stakes and 101 added.
The largest buyer was Farallon Capital Management, adding an estimated $57.3M. The largest seller was Darwin Global Management, exiting entirely with an estimated $80.8M sold.
- 225 institutional investors held Biohaven (BHVN) as of Q2 2024, down from 243 in Q1 2024.
- Funds reported $2.88B of Biohaven stock for Q2 2024, down 29% quarter-over-quarter.
- 40 funds opened new Biohaven positions in Q2 2024 and 56 closed out, a net change of -16 holders.
- The largest Biohaven buyer in Q2 2024 was Farallon Capital Management, an estimated $57.3M added.
- The largest Biohaven seller in Q2 2024 was Darwin Global Management, an estimated $80.8M sold.
Based on aggregated 13F filings for Q2 2024.